This is the user sandbox of Fingerlickin12. A user sandbox is a subpage of the user's user page. It serves as a testing spot and page development space for the user and is not an encyclopedia article. Create or edit your own sandbox here.

Other sandboxes: Main sandbox | Template sandbox

Finished writing a draft article? Are you ready to request review of it by an experienced editor for possible inclusion in Wikipedia? Submit your draft for review!

Research

Medications

Besides teaching individuals with multiple sclerosis how to live with the disease, it is important to be able to manage symptoms like bladder problems, fatigue, itching, pain, bowel dysfunction, and even sexual problems. This can be done by taking different types of medications, such as Tysabri. ^[1] Corticosteroids can be used to help limit the impact of acute relapses, while interferon beta was thought to prevent relapses. ^[2]. Another recent study on Tysabri has been shown to reduce the worsening of multiple sclerosis. ^[3] Although it was previously thought that interferon beta helps, recent studies suggest that it actually has no impact on the effects of multiple sclerosis and that relapses are just as likely to occur. ^[4]

^ "Medications." National Multiple Sclerosis Society. N.p., n.d. Web. 16 Apr. 2014. <http://www.nationalmssociety.org/Treating-MS/Medications#section-2>.
^ Shirani, Afsaneh, Yinshan Zhao, Mohammad Ehsanul Karim, Charity Evans, Elaine Kingwell, Mia L. Van Der Kop, Joel Oger, Paul Gustafson, John Petkau, and Helen Tremlett. "Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis." Jama 308.3 (2012): n. pag. Print.
^ "Treating Multiple Sclerosis." With TYSABRI (natalizumab). N.p., n.d. Web. 17 Apr. 2014. <http://www.tysabri.com/treating-multiple-sclerosis.xml>.
^ "Treating Multiple Sclerosis." With TYSABRI (natalizumab). N.p., n.d. Web. 17 Apr. 2014. <http://www.tysabri.com/treating-multiple-sclerosis.xml>.

[1] "Medications." National Multiple Sclerosis Society. N.p., n.d. Web. 16 Apr. 2014. <http://www.nationalmssociety.org/Treating-MS/Medications#section-2>.

[2] Shirani, Afsaneh, Yinshan Zhao, Mohammad Ehsanul Karim, Charity Evans, Elaine Kingwell, Mia L. Van Der Kop, Joel Oger, Paul Gustafson, John Petkau, and Helen Tremlett. "Association Between Use of Interferon Beta and Progression of Disability in Patients With Relapsing-Remitting Multiple Sclerosis." Jama 308.3 (2012): n. pag. Print.

[3] "Treating Multiple Sclerosis." With TYSABRI (natalizumab). N.p., n.d. Web. 17 Apr. 2014. <http://www.tysabri.com/treating-multiple-sclerosis.xml>.

[4] "Treating Multiple Sclerosis." With TYSABRI (natalizumab). N.p., n.d. Web. 17 Apr. 2014. <http://www.tysabri.com/treating-multiple-sclerosis.xml>.

[1]